Legal & General Group
EVH icon

Legal & General Group’s Evolent Health EVH Stock Holding History

Legal & General Group’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$55.5K Sell
24,348
-101,535
-81% -$322K ﹤0.01% 2664
2025
Q4 		$504K Sell
125,883
-246
-0.2% -$1.37K ﹤0.01% 2429
2025
Q3 		$1.07M Sell
126,129
-2,576
-2% -$25K ﹤0.01% 2222
2025
Q2 		$1.45M Buy
128,705
+19,576
+18% +$180K ﹤0.01% 2100
2025
Q1 		$1.03M Sell
109,129
-3,559
-3% -$36K ﹤0.01% 2177
2024
Q4 		$1.27M Buy
112,688
+4,063
+4% +$71.4K ﹤0.01% 2161
2024
Q3 		$3.07M Sell
108,625
-7,262
-6% -$187K ﹤0.01% 1800
2024
Q2 		$2.22M Buy
115,887
+3,740
+3% +$95.5K ﹤0.01% 1899
2024
Q1 		$3.68M Sell
112,147
-103
-0.1% -$3.29K ﹤0.01% 1660
2023
Q4 		$3.71M Buy
112,250
+390
+0.3% +$11K ﹤0.01% 1672
2023
Q3 		$3.05M Buy
111,860
+16,720
+18% +$465K ﹤0.01% 1699
2023
Q2 		$2.88M Buy
95,140
+14,709
+18% +$476K ﹤0.01% 1745
2023
Q1 		$2.61M Buy
80,431
+7,305
+10% +$231K ﹤0.01% 1757
2022
Q4 		$2.05M Buy
73,126
+717
+1% +$20.6K ﹤0.01% 1873
2022
Q3 		$2.6M Sell
72,409
-3,247
-4% -$114K ﹤0.01% 1721
2022
Q2 		$2.32M Sell
75,656
-2,271
-3% -$66.2K ﹤0.01% 1818
2022
Q1 		$2.52M Buy
77,927
+594
+0.8% +$15.6K ﹤0.01% 1888
2021
Q4 		$2.14M Buy
77,333
+570
+0.7% +$16.4K ﹤0.01% 2004
2021
Q3 		$2.38M Buy
76,763
+18,634
+32% +$447K ﹤0.01% 1938
2021
Q2 		$1.23M Buy
58,129
+13,263
+30% +$266K ﹤0.01% 2153
2021
Q1 		$907K Buy
44,866
+795
+2% +$15.1K ﹤0.01% 2213
2020
Q4 		$707K Sell
44,071
-20,878
-32% -$276K ﹤0.01% 2187
2020
Q3 		$806K Sell
64,949
-3,195
-5% -$37.6K ﹤0.01% 2090
2020
Q2 		$485K Buy
68,144
+32,791
+93% +$220K ﹤0.01% 2176
2020
Q1 		$192K Sell
35,353
-2,963
-8% -$26.5K ﹤0.01% 2288
2019
Q4 		$347K Buy
38,316
+2,052
+6% +$16.7K ﹤0.01% 2294
2019
Q3 		$261K Buy
36,264
+7,100
+24% +$51K ﹤0.01% 2299
2019
Q2 		$232K Buy
29,164
+1,187
+4% +$14.1K ﹤0.01% 2312
2019
Q1 		$352K Buy
27,977
+282
+1% +$4.46K ﹤0.01% 2220
2018
Q4 		$553K Buy
27,695
+1,838
+7% +$42.5K ﹤0.01% 2095
2018
Q3 		$734K Hold
25,857
– – ﹤0.01% 2036
2018
Q2 		$544K Sell
25,857
-580
-2% -$11K ﹤0.01% 2081
2018
Q1 		$377K Buy
26,437
+3,811
+17% +$54.5K ﹤0.01% 2171
2017
Q4 		$280K Buy
22,626
+774
+4% +$10.9K ﹤0.01% 2228
2017
Q3 		$390K Buy
21,852
+12,006
+122% +$247K ﹤0.01% 2143
2017
Q2 		$250K Buy
9,846
+5,418
+122% +$130K ﹤0.01% 2228
2017
Q1 		$99K Sell
4,428
-63
-1% -$1.21K ﹤0.01% 2546
2016
Q4 		$66K Buy
4,491
+2,207
+97% +$43.5K ﹤0.01% 2788
2016
Q3 		$55K Hold
2,284
– – ﹤0.01% 2472
2016
Q2 		$43K Buy
+2,284
New +$31.4K ﹤0.01% 2545

Other funds holding EVH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Legal & General Group's EVH Position: Q1 2026 in Review

Legal & General Group reduced its Evolent Health (EVH) stake by 81% in Q1 2026, selling an estimated $322K and leaving 24,348 shares worth $55.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2664.

Legal & General Group first reported a position in EVH in Q2 2016 and has held it in 40 quarters since. The position peaked at $3.71M in Q4 2023. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • Legal & General Group held 24,348 shares of Evolent Health worth $55.5K as of Q1 2026.
  • Legal & General Group sold 101,535 Evolent Health shares in Q1 2026, an estimated $322K.
  • Evolent Health made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #2664 holding.
  • Legal & General Group first reported a position in Evolent Health in Q2 2016 and has held it in 40 quarters since.
  • Legal & General Group's Evolent Health position peaked at $3.71M in Q4 2023.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.